[1]
K. Stanič, MD, PhD, M. Vrankar, and N. Turnšek, “Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients”, RO, vol. 53, no. 4, pp. 453-458, Dec. 2019.